mirtazapine 30 mg
1 INDICATIONS AND USAGE Mirtazapine tablets are indicated for the treatment of major depressive disorder (MDD) in adults [see Clinical Studies (14) ]. Mirtazapine tablets are indicated for the treatment of major depressive disorder (MDD) in adults. ( 1 )
Aurobindo Pharma Limited
OVAL BROWN 0 9 A
0 9 A OVAL BROWN
Related Pills
mirtazapine 30 mg
aurobindo pharma limited
mirtazapine 30 mg
aurobindo pharma limited
mirtazapine 30 mg
Aurobindo Pharma Limited
Mirtazapine 15 mg
Aurobindo Pharma Limited
Mirtazapine 15 mg
Aurobindo Pharma Limited
mirtazapine 30 mg
aurobindo pharma limited
Mirtazapine 30 MG Oral Tablet
Aurolife Pharma LLC
Mirtazapine 30 MG Oral Tablet
Aurolife Pharma LLC
Mirtazapine 30 mg
Aphena Pharma Solutions - Tennessee, LLC
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING
MIRTAZAPINE tablets, USP are supplied as: 7.5 mg Tablets – white, biconvex, capsule shaped film coated tablets with “11” debossed on one side and “A” debossed on the other side. Bottles of 30 NDC 65862-001-30 Bottles of 60 NDC 65862-001-60 Bottles of 90 NDC 65862-001-90 Bottles of 100 NDC 65862-001-01 Bottles of 500 NDC 65862-001-05 15 mg Tablets – yellow, biconvex, capsule shaped film coated tablets with a score line in between “0” and “8” on one side and “A” debossed on the other side. Bottles of 30 NDC 65862-031-30 Bottles of 60 NDC 65862-031-60 Bottles of 90 NDC 65862-031-90 Bottles of 100 NDC 65862-031-01 Bottles of 500 NDC 65862-031-05 30 Unit-of-use packaging NDC 65862-031-32 30 mg Tablets – Reddish brown, biconvex, capsule shaped film coated tablets with a score line in between “0” and “9” on one side and “A” debossed on the other side. Bottles of 30 NDC 65862-003-30 Bottles of 60 NDC 65862-003-60 Bottles of 90 NDC 65862-003-90 Bottles of 100 NDC 65862-003-01 Bottles of 500 NDC 65862-003-05 30 Unit-of-use packaging NDC 65862-003-32 45 mg Tablets – white, biconvex, capsule shaped film coated tablets with “10” debossed on one side and “A” debossed on the other side. Bottles of 30 NDC 65862-032-30 Bottles of 60 NDC 65862-032-60 Bottles of 90 NDC 65862-032-90 Bottles of 100 NDC 65862-032-01 Bottles of 500 NDC 65862-032-05 30 Unit-of-use packaging NDC 65862-032-32 Storage Store at 25°C (77°F); excursions permitted to 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature]. Protect from light and moisture.
More pills like OVAL 0 9 A